Paradigm Biocapital Advisors LP
Filing Date
Global Rank
#950
/ 7,976
▲ 157
Top Industry
Biotechnology
97.3%
3Y Alpha vs SPY
-3.4%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
16 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+61.7%
SPY
+76.3%
Annualised alpha
-3.4%
Max drawdown
−47.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
31 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
15.8%
−3.4 pts
Top 5
49.3%
−6.1 pts
Top 10
69.2%
−4.1 pts
HHI
714
Diversified−157
Portfolio Trend
16 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,883,920,399 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
12 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals, Inc. | +1,731,044 | 2,873,555 | $115,344,497 | |
| ERAS | Erasca, Inc. | +1,652,835 | 13,560,017 | $29,560,837 | |
| PHVS | Pharvaris N.V. | +772,583 | 1,835,494 | $45,795,575 | |
| APGE | Apogee Therapeutics, Inc. | +563,127 | 1,521,757 | $60,459,405 | |
| PCVX | Vaxcyte, Inc. | +411,918 | 3,784,755 | $136,326,875 | |
| SRRK | Scholar Rock Holding Corp | +409,191 | 2,009,745 | $74,842,903 | |
| ALKS | Alkermes plc. | +343,765 | 1,719,334 | $51,580,020 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | +207,221 | 2,550,774 | $106,239,737 | |
| RVMD | Revolution Medicines, Inc. | +130,000 | 6,223,291 | $290,627,689 | |
| OCUL | Ocular Therapeutix, Inc | +76,967 | 3,497,307 | $40,883,518 | |
| OLMA | Olema Pharmaceuticals, Inc. | +30,000 | 6,794,172 | $66,514,943 | |
| EWTX | Edgewise Therapeutics, Inc. | +27,787 | 6,170,131 | $100,079,524 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
7 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| COGT | Cogent Biosciences, Inc. | −7,196,051 | 3,156,398 | $45,325,875 | |
| IRON | Disc Medicine, Inc. | −963,255 | 247,716 | $16,369,073 | |
| LENZ | LENZ Therapeutics, Inc. | −643,605 | 1,073,461 | $50,001,813 | |
| SYRE | Spyre Therapeutics, Inc. | −403,179 | 1,467,266 | $24,591,378 | |
| TARS | Tarsus Pharmaceuticals, Inc. | −310,401 | 2,665,698 | $158,422,432 | |
| BBIO | BridgeBio Pharma, Inc. | −281,487 | 684,277 | $35,541,347 | |
| VRDN | Viridian Therapeutics, Inc.DE | −132,223 | 2,609,353 | $56,309,837 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ABVX | Abivax S.A. | 1,564,196 | $132,800,240 | |
| GMAB | Genmab A/S | 3,816,851 | $117,062,820 | |
| URGN | UroGen Pharma Ltd. | 4,216,084 | $84,110,875 | |
| EYPT | EyePoint, Inc. | 2,005,365 | $28,556,397 | |
| TNGX | Tango Therapeutics, Inc. | 3,086,184 | $25,923,945 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | 1,900,000 | $25,821,000 | |
| DYN | Dyne Therapeutics, Inc. | 1,898,950 | $24,021,717 | |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 1,866,141 | $21,609,912 | |
| GPCR | Structure Therapeutics Inc. | 372,869 | $10,440,332 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
4 positions
31 positions ·
$2,883,920,399 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| NUVL |
Nuvalent, Inc.
Healthcare
|
Held | 5,269,433 | $455,700,565 | 15.80% | |
| ACLX |
Arcellx, Inc.
Healthcare
|
Held | 4,649,016 | $381,684,213 | 13.23% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 6,223,291 | $290,627,689 | 10.08% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,665,698 | $158,422,432 | 5.49% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 3,784,755 | $136,326,875 | 4.73% | |
| ABVX |
Abivax S.A.
Healthcare
|
NEW | 1,564,196 | $132,800,240 | 4.60% | |
| GMAB |
Genmab A/S
Healthcare
|
NEW | 3,816,851 | $117,062,820 | 4.06% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 2,873,555 | $115,344,497 | 4.00% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Added | 2,550,774 | $106,239,737 | 3.68% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Added | 6,170,131 | $100,079,524 | 3.47% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
NEW | 4,216,084 | $84,110,875 | 2.92% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 2,009,745 | $74,842,903 | 2.60% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
Held | 2,920,258 | $71,371,105 | 2.47% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Added | 6,794,172 | $66,514,943 | 2.31% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Added | 1,521,757 | $60,459,405 | 2.10% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Reduced | 2,609,353 | $56,309,837 | 1.95% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 1,719,334 | $51,580,020 | 1.79% | |
| LENZ |
LENZ Therapeutics, Inc.
Healthcare
|
Reduced | 1,073,461 | $50,001,813 | 1.73% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 1,835,494 | $45,795,575 | 1.59% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 3,156,398 | $45,325,875 | 1.57% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Added | 3,497,307 | $40,883,518 | 1.42% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 684,277 | $35,541,347 | 1.23% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 13,560,017 | $29,560,837 | 1.03% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
NEW | 2,005,365 | $28,556,397 | 0.99% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 3,086,184 | $25,923,945 | 0.90% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
NEW | 1,900,000 | $25,821,000 | 0.90% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 1,467,266 | $24,591,378 | 0.85% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
NEW | 1,898,950 | $24,021,717 | 0.83% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
NEW | 1,866,141 | $21,609,912 | 0.75% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Reduced | 247,716 | $16,369,073 | 0.57% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
NEW | 372,869 | $10,440,332 | 0.36% |